A pooled analysis of serious infections and herpes zoster-related disease in Asian patients with rheumatoid arthritis treated with peficitinib (ASP015K) over a median of 3 years.

导出 LinkOut

翻译打印收藏纠错

作者： Yoshiya,Tanaka ^[1] ; Tsutomu,Takeuchi ^[2] ; Daisuke,Kato ^[3] ; Yuichiro,Kaneko ^[3] ; Musashi,Fukuda ^[3] ; Hiroyuki,Izutsu ^[3] ; Mitsuhiro,Rokuda ^[3]

作者单位： The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan. ^[1] Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. ^[2] Astellas Pharma Inc., Tokyo, Japan. ^[3]

关键词 Herpes zoster Janus kinase inhibitor peficitinib rheumatoid arthritis serious infection

主题词金刚烷(Adamantane);抗风湿药(Antirheumatic Agents);关节炎, 类风湿(Arthritis, Rheumatoid);带状疱疹(Herpes Zoster);人类(Humans);烟酰胺(Niacinamide);泼尼松龙(Prednisolone)

DOI 10.1093/mr/roab069

PMID 34918131

发布时间 2024-12-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交